A targeted molecular-imaging method under development at Rochester Institute of Technology could help detect early stages of prostate cancer and improve image-directed biopsies.
(PRWeb June 24, 2015)
Read the full story at http://www.prweb.com/releases/2015/06/prweb12803563.htm